You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 10, October 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Surgical Physiology, Other
 •Prognosis/ Outcomes
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Significance of Circulating B-Type Natriuretic Peptide in Sepsis

Tetsuji Fujita, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their interesting study comparing circulating B-type natriuretic peptide (BNP) concentrations in 13 patients with septic shock with those in 18 patients with sepsis but without shock and 18 age-matched healthy controls, Kandil and colleagues1 found that BNP elevation was correlated with severity of sepsis. They concluded that BNP measurement is useful for predicting the outcomes of patients with septic shock. The mean BNP concentrations, which were measured with a commercially available single-use fluorescence immunoassay, were 849.4 pg/mL in patients with septic shock, 120.0 pg/mL in those having early sepsis without shock, and 100.0 pg/mL in healthy controls. It appears that the method for determining circulating BNP levels has not been standardized. In a recent study that evaluated the validity of BNP as a predictor of postoperative cardiac events in patients undergoing major noncardiac operations, there was about a 25-fold increase in cardiac events in those with . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

B-Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock
Emad Kandil, Joshua Burack, Ahmed Sawas, Haidy Bibawy, Alex Schwartzman, Michael E. Zenilman, and Martin H. Bluth
Arch Surg. 2008;143(3):242-246.
ABSTRACT | FULL TEXT  

RELATED LETTER

Significance of Circulating B-Type Natriuretic Peptide in Sepsis—Reply
Emad Kandil and Martin H. Bluth
Arch Surg. 2008;143(10):1022-1023.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.